254 related articles for article (PubMed ID: 17217363)
41. Stimulation of autoimmunity by toll-like receptor ligands.
Limmer A; Ganss R; Garbi N; Arnold B; Hämmerling GJ
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv15-7. PubMed ID: 16239378
[No Abstract] [Full Text] [Related]
42. Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?
Assenat E; Gerbal-chaloin S; Maurel P; Vilarem MJ; Pascussi JM
Eur J Cancer; 2006 Apr; 42(6):785-92. PubMed ID: 16510279
[TBL] [Abstract][Full Text] [Related]
43. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
[TBL] [Abstract][Full Text] [Related]
44. Toll-like receptors: linking inflammation to metabolism.
Könner AC; Brüning JC
Trends Endocrinol Metab; 2011 Jan; 22(1):16-23. PubMed ID: 20888253
[TBL] [Abstract][Full Text] [Related]
45. Inflammation, a key event in cancer development.
Lu H; Ouyang W; Huang C
Mol Cancer Res; 2006 Apr; 4(4):221-33. PubMed ID: 16603636
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia-inducible factor 1 as one of the "signaling drivers" of Toll-like receptor-dependent and allergic inflammation.
Sumbayev VV; Nicholas SA
Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):287-94. PubMed ID: 20502970
[TBL] [Abstract][Full Text] [Related]
47. Toll-like receptors: a family of innate sensors of danger that alert and drive immunity.
Montero Vega MT; de Andrés Martín A
Allergol Immunopathol (Madr); 2008; 36(6):347-57. PubMed ID: 19150035
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor signaling and its relevance to intestinal inflammation.
Cario E; Podolsky DK
Ann N Y Acad Sci; 2006 Aug; 1072():332-8. PubMed ID: 17057213
[TBL] [Abstract][Full Text] [Related]
49. At the crossroads of inflammation and cancer.
Clevers H
Cell; 2004 Sep; 118(6):671-4. PubMed ID: 15369667
[TBL] [Abstract][Full Text] [Related]
50. The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation.
Thomas R
Arthritis Res Ther; 2005; 7(4):170-3. PubMed ID: 15987501
[No Abstract] [Full Text] [Related]
51. Signaling pathways bridging microbial-triggered inflammation and cancer.
Kipanyula MJ; Seke Etet PF; Vecchio L; Farahna M; Nukenine EN; Nwabo Kamdje AH
Cell Signal; 2013 Feb; 25(2):403-16. PubMed ID: 23123499
[TBL] [Abstract][Full Text] [Related]
52. Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.
Yeh DW; Huang LR; Chen YW; Huang CF; Chuang TH
J Immunol Res; 2016; 2016():4368101. PubMed ID: 28116318
[TBL] [Abstract][Full Text] [Related]
53. TLRs: linking inflammation and breast cancer.
Bhatelia K; Singh K; Singh R
Cell Signal; 2014 Nov; 26(11):2350-7. PubMed ID: 25093807
[TBL] [Abstract][Full Text] [Related]
54. Immune system's Toll-like receptors have good opportunity for cancer treatment.
Schmidt C
J Natl Cancer Inst; 2006 May; 98(9):574-5. PubMed ID: 16670380
[No Abstract] [Full Text] [Related]
55. Infection & neoplastic growth 101: the required reading for microbial pathogens aspiring to cause cancer.
Bertout J; Thomas-Tikhonenko A
Cancer Treat Res; 2006; 130():167-97. PubMed ID: 16610708
[TBL] [Abstract][Full Text] [Related]
56. Toll-like receptors, tissue injury, and tumourigenesis.
Ioannou S; Voulgarelis M
Mediators Inflamm; 2010; 2010():. PubMed ID: 20871832
[TBL] [Abstract][Full Text] [Related]
57. Toll-like receptor signaling in the liver.
Schwabe RF; Seki E; Brenner DA
Gastroenterology; 2006 May; 130(6):1886-900. PubMed ID: 16697751
[No Abstract] [Full Text] [Related]
58. [Viewing from the toll-like receptor/nuclear factor-kappaB signaling pathway to explore the immunomodulatory mechanism of Chinese drugs].
Zhou HG; Chen HB; Wu MH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):884-8. PubMed ID: 21038663
[TBL] [Abstract][Full Text] [Related]
59. NF-κB, inflammation, immunity and cancer: coming of age.
Taniguchi K; Karin M
Nat Rev Immunol; 2018 May; 18(5):309-324. PubMed ID: 29379212
[TBL] [Abstract][Full Text] [Related]
60. Fat uses a TOLL-road to connect inflammation and diabetes.
Kim JK
Cell Metab; 2006 Dec; 4(6):417-9. PubMed ID: 17141623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
